Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
CLX · NYSE · United States · Specialty Cleaning, Polishing And Sanitation Preparations
In shortCLOROX CO /DE/ is profitable, generates cash and carries heavy debt, with revenue stable (+0.2% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | – | n/a |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 11.4% | 66/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 249.6% | 100/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 0.84× | 3/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 7.74× | 0/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | – | n/a |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 10.7% | 63/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 0.94× | 80/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 5.5% | 91/100 |
| Operating margin volatility | – | n/a |
Weight in the score: 20%
| Revenue growth, 3-year average | -0.0% | 17/100 |
|---|---|---|
| EPS growth, 3-year average | 20.5% | 100/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 7,341 | 7,107 | 7,389 | 7,093 | 7,104 |
| Cost of revenue | 4,142 | 4,562 | 4,481 | 4,045 | 3,891 |
| Gross profit | 3,199 | 2,545 | 2,908 | 3,048 | 3,213 |
| Research & development | 149 | 132 | 138 | 126 | 121 |
| Selling, general & admin | 1,004 | 954 | 1,183 | 1,167 | 1,124 |
| Interest expense | 99 | 106 | 90 | 90 | 88 |
| Pre-tax income | 900 | 607 | 238 | 398 | 1,078 |
| Income tax | 181 | 136 | 77 | 106 | 254 |
| Net income | 710 | 462 | 149 | 280 | 810 |
| Diluted EPS | $5.58 | $3.73 | $1.20 | $2.25 | $6.52 |
| Diluted shares (millions) | 127 | 124 | 124 | 125 | 124 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
Not computed: a required balance-sheet item is missing.
7/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Apr 30, 2026